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The mechanism by which urine is concentrated in the
mammalian kidney remains incompletely understood. Urea is
the dominant urinary osmole in most mammals and may be
concentrated a 100-fold above its plasma level in humans
and even more in rodents. Several facilitated urea
transporters have been cloned. The phenotypes of mice with
deletion of the transporters expressed in the kidney have
challenged two previously well-accepted paradigms
regarding urea and sodium handling in the renal medulla but
have provided no alternative explanation for the
accumulation of solutes that occurs in the inner medulla. In
this review, we present evidence supporting the existence of
an active urea secretion in the pars recta of the proximal
tubule and explain how it changes our views regarding
intrarenal urea handling and UT-A2 function. The transporter
responsible for this secretion could be SGLT1, a sodium-
glucose cotransporter that also transports urea. Glucagon
may have a role in the regulation of this secretion. Further,
we describe a possible transfer of osmotic energy from the
outer to the inner medulla via an intrarenal Cori cycle
converting glucose to lactate and back. Finally, we propose
that an active urea transporter, expressed in the urothelium,
may continuously reclaim urea that diffuses out of the ureter
and bladder. These hypotheses are all based on published
findings. They may not all be confirmed later on, but we
hope they will stimulate further research in new directions.
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Efficient water conservation is a challenge for terrestrial
mammals. Concentrating urine several fold above plasma
osmolality (up to 4- to 5-fold in humans and to 15- to 20-fold
in some rodents) is an important feature of water conserva-
tion, allowing the excretion of soluble wastes in a relatively
limited amount of fluid. The loop shape of the mammalian
nephrons and the unique vascular–tubular relationships of the
renal medulla are key factors in this concentrating function.1
However, the mechanism by which urine is concentrated
remains incompletely understood and is not satisfactorily
simulated by the most sophisticated mathematical models
designed so far.2–5 The active transport that occurs in the
thick ascending limb of Henle’s loops and in the collecting
duct (CD) in the cortex and outer medulla (OM) provide
osmotic energy that accounts for the rise in urine
osmolality within these zones, but the further concentra-
tion that is observed in the inner medulla (IM) remains
largely unexplained.
Urea, a small water-soluble molecule, is the major end
product of protein metabolism in mammals and is the most
abundant solute in the urine (at least in omnivores and
carnivores). Because its concentration in the blood plasma is
relatively low (4–10mmol/l) compared with that of other
solutes such as sodium (140mmol/l), urea representso2% of
the filtered solutes but becomes about 40–50% of all solutes in
the urine (for a western-type diet in humans). To excrete this
daily load, urea is concentrated up to 100 times in urine with
respect to plasma, and the bulk of water reabsorbed by the
kidney to concentrate urine is actually devoted to the
concentration of urea.6,7 Moreover, urea has long been known
to improve the concentration of other solutes in the urine.8–11
In the past two decades, several facilitated urea transpor-
ters (UTs) have been cloned, and their localization in the
kidney and contribution to the concentrating mechanism
have been described (see reviews by Sands12 and Bagnasco13).
Mouse models with knockout (KO) of several of these
transporters have brought some new insights into urea
movements in the kidney11,14–17 but provided no adequate
explanation for the progressive rise in osmolality that occurs
in the IM. Moreover, they have challenged at least two
previously well-accepted paradigms regarding urea and
sodium handling in the renal medulla (see further).
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Several other nitrogenous end products, including am-
monia, uric acid, and (to a modest extent) creatinine, are
known to be secreted actively in the nephron, i.e., against an
unfavorable transepithelial concentration difference. In con-
trast, urea is usually not considered to be actively secreted in
the mammalian kidney in spite of a few sporadic publications
in favor of such a secretion.7,18–21 Recent findings in mice
have given a new impulse for the likelihood of an active
secretion of urea because two studies found excretion rates of
urea that exceed 100% of the filtered load.22,23
Active urea transport has been well characterized func-
tionally in many different living beings, from unicellular
organisms to mammals. It may serve three different functions.
One is nitrogen uptake from the external milieu, as occurs in
certain unicellular organisms that possess the enzyme urease
and are thus able to break down urea.24,25 Another is urea
conservation in elasmobranchs (through gills and kidneys26)
and some terrestrial amphibians (through the ventral skin in
some frogs or toads27–32) that use urea as an ‘osmotic buffer’
in plasma and extracellular fluids to compensate for the
hyperosmolality of the sea water (elasmobranchs) or prevent
excessive water loss through the skin (terrestrial amphibians).
Renal urea conservation may also be important in mammals
with a low protein intake (herbivores and especially rumi-
nants,33–38 or rats fed a protein-poor diet39), in association
with a bacterial microflora able to hydrolyze urea in their
digestive tract. This allows the reuse of urea nitrogen that
would otherwise be lost in the urine.7 Finally, active urea
secretion may contribute to more efficient urea excretion,
and especially to urea concentration in the urine, as a means
to get rid of nitrogen wastes without excessive water demand.
This occurs in the kidney of some frogs40–42 and probably
also in the mammalian kidney, as will be explained below.
Until now, a few studies have provided convincing evidence
for both active urea reabsorption and active urea secretion in
the CD of the mammalian kidney. Significant Na-coupled
active urea reabsorption from lumen to peritubular space
appears in the upper third of the inner medullary CD (IMCD)
of rats after sustained low protein intake.39,43–45 From a
different perspective, a small active urea secretion has also been
demonstrated functionally in the very terminal part of the
IMCD of normal rats,46 but this could account only for an
extremely small addition of urea to the urine (see section
‘Does active urea reabsorption in the lower urinary tract
contribute to maintain high urea concentration in the urine?’).
The molecular structure of several different active urea
transporters has been identified in plants,47 bacteria,48–50
yeast,25,51 and fungi,52,53 but no homology with the corres-
ponding genes has been found in the mammalian genome. It
is somewhat surprising that, with so much recent progress in
the identification of membrane transporters, the molecular
structure of the transporters responsible for active urea
transport in vertebrates has not yet been identified.
In this review, we will present the evidence supporting an
active urea secretion in the pars recta of the mammalian
proximal tubule and explain how it changes our views
regarding urea handling in the thin descending limbs (TDLs).
We will also propose several new hypotheses. The first two
concern the transporter that could be responsible for this
urea secretion, and a possible transfer of osmotic energy from
the outer to the IM, taking advantage of the unique
vascular–tubular spatial relationships in the medulla. The
last hypothesis deals with urea handling in the urinary tract.
These hypotheses are based on a number of original findings
reported in the literature. Maybe these hypotheses will turn
to be wrong in a more or less distant future, as have many
previous hypotheses. Our aim in writing this review is to
stimulate further research in new directions by providing
novel provocative insights into poorly explored mechanisms
and pathways that could be involved in the production of
concentrated urine in mammals.
ACTIVE SECRETION OF UREA IN THE PARS RECTA AND
TRANSFER TO THE INNER MEDULLA
The mechanism by which urea is concentrated in the urine is
only partially understood. In the past four decades, it has been
understood that it depends (1) on several facilitated UTs
expressed in some limited portions of the TDL, CD (see note
1 below), and descending vasa recta, all located in the medulla
(see reviews by Sands,12 Bagnasco,13 Bankir,22 and Smith and
Fenton54), allowing the delivery of concentrated urea to the
most inner part of the IMCD, and (2) on a complex intrarenal
recycling that continuously brings back to the IM part of the
urea that tends to escape through the venous blood in
ascending vasa recta22 (Note 1: Although the CD is often
considered to be part of the ‘distal nephron’, this structure
does not belong to the ‘nephron’ proper as it has a different
embryonic origin (ectoderm for the CD and mesoderm for
the nephron)).
For several decades, the conventional paradigm has been
that this recycling process involves the reentry of inner
medullary urea along the descending vasa recta (through UT-B)
and in specialized sections of the loops of Henle (through
UT-A2) as illustrated in Figure 1 (left panel). The close
association of descending and ascending vasa recta and the
paucity of interstitial tissue in the vascular bundles of the
inner stripe of the OM favor countercurrent exchange of urea
between arterial and venous blood (going to and coming from
the IM). Evidence for intrarenal urea recycling through the
loops of Henle came from micropuncture experiments that
showed that, in all species studied, during ‘antidiuretic’
conditions, more urea flows through the early distal tubule
(at the exit of the loop of Henle) than in the late proximal
tubule (the last accessible segment before the loop of Henle).55–60
In the rat, the close proximity of the TDLs of short-looped
nephrons with the vascular bundles in the inner stripe
suggests intense countercurrent exchange of urea between
ascending vasa recta and TDLs. In the mouse and in some
desert-adapted rodents, TDLs are even intermingled among
descending and ascending vasa recta within ‘complex’ vascular
bundles, making these exchanges even more efficient.61–63 A
parallel has been made between these structural adaptations
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and the urine concentrating ability in different rodents.63 For
detailed description of the vasculo-tubular relationships of
the mammalian renal medulla, see reviews by Bankir et al.,1
Bankir and de Rouffignac,61 Kriz,62 Beeuwkes and Bonven-
tre,64 Kriz.65 However, in spite of this favorable anatomical
configuration, the magnitude of the observed urea addition
in the loops66 seems difficult to reconcile with the models
proposed for generating hyperosmolality in the IM by passive
mechanisms.
Most of the studies conducted in transgenic mice with
deletion of one or more of the facilitated UTs have confirmed
and validated many previous concepts about urea handling in
the kidney. However, two previous features, assumed to be
important steps in the concentrating mechanism, have been
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Figure 1 | Intrarenal urea movements according to the classical theory or to the new concept that assumes an active secretion of
urea in the pars recta. Common features to both panels. The course through the four kidney zones of a short-looped and a long-
looped nephron and a collecting duct (CD) is depicted, along with arterial (light red) and venous (light blue) vasa recta (descending
and ascending vasa recta, DVR and AVR, respectively). CO, cortex; OS and IS, outer and inner stripe of the outer medulla, respectively;
IM, inner medulla. In the OS, ascending vasa recta are very numerous and make close contact with the pars recta (see Figure 2). In the
‘vascular bundles’ of the IS and in the IM, ascending and descending vasa recta run in parallel with blood flowing in opposite
directions. Descending vasa recta express UT-B and AQP1 along their entire length (not shown), and ascending vasa recta are
fenestrated. Thus, urea can diffuse rapidly through these two types of vessels that form a ‘countercurrent exchanger’. Simultaneously,
water can be short-circuited from the descending vasa recta to the ascending vasa recta, so as to minimize water delivery to the
IM. Note that ascending vasa recta are more numerous than descending vasa recta in the IS and IM, although only one of each is
drawn here for clarity. Expression of UT-A2 (in thin descending limbs) and UT-A1/3 (in terminal IMCD) along discrete regions of these
structures is shown as a green lining.
Left (previous model): Concentrated urea (A) is delivered to the IM through the terminal IMCD via UT-A1/3/4 and diffuses in the inner
medullary interstitium (B). It is taken up by ascending vasa recta (C) and is then recycled through two different routes: a vascular route
(D) by countercurrent exchange between ascending and descending vasa recta, and a tubular route (E) via the thin descending limbs
of short-looped nephrons expressing UT-A2.
Right (new model): New features are shown by red arrows and numbers. Urea is assumed to be actively secreted in the medullary pars recta
of both short- and long-looped nephrons in the OS (1) (and possibly in the medullary rays of the cortex, not shown). This provides a flow of
concentrated urea in the thin limbs. When facing a segment expressing UT-A2 in short-looped nephrons, some urea diffuses into the nearby
ascending vasa recta (2) and is then trapped into the countercurrent exchanger (3). It is then taken down to the IM. In long-looped nephrons,
some of the urea flows directly toward the IM where it brings concentrated urea that may diffuse into the interstitium (4), thus contributing
to enhance urea accumulation in the IM. In both types of loops, the urea that remains in the lumen (having escaped diffusion through UT-A2)
flows in the nephron, down to the IMCD along a relatively long tubular route (5 and 6).
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challenged. (1) Urea recycling through UT-A2 in the TDLs of
short-looped nephrons is not important for urine concentra-
tion.17 (2) Sodium chloride can accumulate in the IM, even
in the absence of urea delivery at the tip of the papilla.23,67
Thus, the classical views about how urine gets concentrated
in the kidney and how urea contributes to this concentration
need to be revised, and new hypotheses are needed to
reconcile former observations with the new knowledge
acquired from transgenic mice models.
Results observed in UT-B KO mice confirmed the major
role of efficient countercurrent exchange of urea between
ascending and descending vasa recta, but also suggested that
the recycling of urea in the loops of Henle through UT-A2
may be much less important than previously assumed.11
Subsequent results in UT-A2 KO mice showed that it is
indeed the case because these mice showed no urine
concentrating defect.17 Moreover, the suppression of UT-A2
expression in UT-B knockout mice (double UT-B/UT-A2
KO) improved their urine concentrating ability almost to the
level seen in wild-type mice, instead of worsening it, as could
have been expected from previous concepts67 (see further).
These observations suggest (1) that a functional UT-A2, in
the absence of countercurrent exchange in the vasa recta,
contributes to dissipate urea instead of bringing it back to the
medulla, and (2) that the well-established urea addition in
Henle’s loops must occur in another segment of their
descending branch.
Urea secretion in the pars recta
We propose that urea is added to the nephron lumen by
active secretion in the pars recta. Uphill urea transport has
been well characterized in the renal tubule of amphibians, in
which it allows urea to be concentrated in the urine five- to
sevenfold above the plasma level, despite the inability of their
kidney to raise urine osmolality as a whole above that of
plasma.40,68 In mammals, this secretion likely occurs in the
pars recta of the proximal tubule, and is probably most
intense in the portion of the pars recta located in the outer
stripe of the OM. In this region, the arterial capillary network
is scarce and most of the blood supply is provided by
abundant venous vasa recta that ascend from the IM and
share a large surface area of contact with the pars recta
(Figure 2). In addition to the urea that is present in the blood
entering the medulla (issued from the efferent arterioles of the
juxtamedullary glomeruli), ascending vasa recta also carry
some of the urea brought by the CDs into the inner
medullary interstitium. Note that the medullary pars recta is
already known to secrete a number of organic compounds
including uric acid, hippurate, cAMP and cGMP, xenobiotics,
and so on.69–74 In aglomerular fishes, a segment analogous to
the mammalian pars recta generates a flow of fluid and
solutes in the nephron by secretion from blood to lumen.75,76
Assuming that urea, similar to other nitrogenous end
products, is actively secreted in the pars recta of the proximal
tubule helps understand the large addition of urea to the
loops of Henle observed in a number of micropuncture
studies of superficial and deep nephrons.55,56,59,66,77–79
Because UT-A2 is expressed only in the deepest 30% of the
short-loop TDL and only weakly in the long-loop TDL,80–82 it
seems unlikely that large amounts of urea could enter
passively in the descending branch of the loops, as had been
assumed in previous models. The finding that mice with
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Figure 2 |Vascular supply of the outer medulla. Microfil filling of arterial (left) and venous vasculature (middle) and a cross-section of
the kidney at the level of the outer stripe (right), illustrating the high surface area of contact between pars recta and venous vasa recta.
In the outer stripe (OS), the arterial blood supply is scarce because the efferent arterioles of the juxtamedullary glomeruli do not form
abundant capillary networks as they do further down in the inner stripe. The blood supply of the proximal tubule pars recta (the nephron
segment occupying the largest volume in the OS) is almost exclusively provided by the ascending vasa recta (shown by ‘v’ in the
right panel) and well visible in the middle panel. *, descending vasa recta. c, collecting duct; d, distal tubule (thick ascending limb);
p, proximal tubule (pars recta).
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UT-A2 deletion exhibit no urine concentrating defect in
normal conditions17 reinforces the hypothesis that urea
addition in the loops of Henle does not occur in the TDLs
and thus has to occur upstream. Using a mathematical model
of the renal medulla, Layton and Layton83 have shown that
urea secretion in the pars recta of either the short loops alone,
or the short and long loops, significantly improves the
efficiency of the urine concentrating mechanism.
New role for UT-A2 in the transfer of urea to the IM
through long and short loops
The consequences of an active urea secretion in the pars recta
are illustrated in Figure 1, right panel. Because AQP1 is not
expressed in the TDLs of most short loops and not at all in
the TDLs of long loops in the OM,82 no water can dilute the
urea that has been secreted upstream. As a result, urea is most
probably more concentrated in the thin-limb lumen than in
the surrounding tissues.
Urea handling in short and long loops. In the short loops,
urea secreted upstream may diffuse out of the TDL in the
short subsegment expressing UT-A2 (Figure 1, right panel)
rather than be added to the TDL, as assumed previously
(Figure 1, left panel). This could seem counterproductive for
the urine concentrating mechanism, but it is not so because
urea should be rapidly trapped in the nearby countercurrent
exchanger formed by the ascending and descending vasa
recta. In the vascular bundles of the inner stripe, these vessels
run in parallel and in close contact, with virtually no
interstitium. The close association of TDLs with the vascular
bundles in the inner stripe in rodents with a high urine
concentrating ability favors countercurrent exchanges be-
tween TDLs and ascending vasa recta.61–63,65 These exchanges
are further facilitated by the fact that UT-A2 is expressed only
in the lowest third of the TDL. This allows urea entry in the
deepest portion of the vascular bundles in the inner stripe
and subsequent countercurrent exchange between ascending
and descending vasa recta in the more superficial part of the
inner stripe (Figure 1, right panel).
In the long loops, urea secretion in the pars recta will
bring concentrated urea down to the IM. This explains the
massive addition of urea observed by micropuncture at the
tip of Henle’s loops in the rat renal papilla (three to five times
the filtered load), an addition that, as stated by the authors,
could not be explained by passive mechanisms.66 Part of this
urea will diffuse out of the thin limbs toward the interstitium
in the portions of the long-loop TDLs expressing UT-A2. It
will be taken up by ascending vasa recta and will undergo
countercurrent exchange between ascending and descending
vasa recta in the IM and inner stripe of OM.
In both short and long loops, only a fraction of the urea
will diffuse out in the subsegments expressing UT-A2. The
urea remaining in the lumen will continue its way in the loop,
pass the macula densa, the distal tubule, and will follow to
the CD, thus bringing more urea to the deep IM. In this way,
the short and long loops contribute to deliver the secreted
urea to the deep medulla via both the countercurrent
exchanger (vascular route) and the CDs (tubular route).
This pathway also results in an increased urea concentration
in the fluid passing by the macula densa. A higher urea
concentration in the thick ascending limb probably allows
this segment to bring the luminal sodium concentration to
lower values (for the same total osmolality) and could thus
participate indirectly in the feedback control of glomerular
filtration rate as proposed earlier.6,7,84
The vascular route is shorter and is probably more
efficient when the inner medullary blood flow remains
relatively slow. Countercurrent exchange is less efficient and
urea escape from the IM is more significant if the medullary
blood flow is increased even modestly, e.g., by vasodilation
induced by prostaglandins (produced by inner medullary
interstitial cells85) or by other vasodilatory mediators. The
fact that an increase in medullary blood flow reduces the
urine concentrating ability has been known for a long time. It
‘washes out’ the corticomedullary osmotic gradient, mainly
by compromising countercurrent exchange of solutes and
short circuit of water in the IM.
In summary, urea secretion in the pars recta brings a
relatively large amount of urea in the nephron lumen that
adds to the filtered urea remaining after proximal tubule
reabsorption. This allows a greater urea delivery to the
medullary CD. Some of the secreted as well as filtered urea is
short-circuited when flowing in the portions of the TDLs
expressing UT-A2 and is carried to the IM through a shorter,
vascular route.
Regulation of UT-A2 abundance by vasopressin and
glucagon. A long-term regulation of the abundance of UT-A2
mRNA and/or protein has been observed in relation to urine
osmolality. In normal rats, the intensity of UT-A2 mRNA in
the OM was found to decrease dose dependently when urine
osmolality was reduced by feeding rats a water-rich gel diet, or
to increase when urine osmolality was raised by chronic
infusion of dDAVP, a selective vasopressin V2 receptor agonist.
Moreover, UT-A2 mRNA appeared in the IM (probably in
TDLs of long loops) when urine osmolality rose above
2000mosm/kg H2O (Figure 3a).
86,87 In Brattleboro rats,
unable to secrete vasopressin because of a single point deletion
in the vasopressin gene, UT-A2 mRNA and UT-A2 protein are
only weakly expressed in the inner stripe and not at all in the
IM. After a chronic treatment with dDAVP, the abundance of
UT-A2 mRNA88 and protein81 was markedly increased in the
outer stripe and appeared in the long-loop TDLs in the IM
(Figure 3b). These changes do not seem to result from a direct
V2 receptor–mediated action of vasopressin on the TDL,
because this nephron segment does not express V2 receptors.
However, autoradiography of rat kidney sections with a
radiolabeled specific V1a agonist suggests that V1a receptors
may be colocalized with UT-A2 in the TDLs.89 As dDAVP
infusion is known to suppress the endogenous release of AVP
(by allowing more water reabsorption and thus decreasing
plasma sodium concentration), this observation raises the
interesting possibility that V1a receptor stimulation may
downregulate UT-A2. This is in good agreement with the
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observation that AVP infusion in rats (combining V2 and V1a
effects) induced almost no change in UT-A2 mRNA expres-
sion, whereas infusion of dDAVP (a pure V2 agonist) induced
a marked increase.88 Other yet unknown mechanisms are
probably involved in the upregulation of UT-A2 mRNA and
protein expression that has been described in mice with
deletion of UT-B, AQP2, or AQP3,90 because AVP is most
probably elevated in these mice that exhibit urine concentrating
defects.
A role for glucagon in renal urea handling may be
assumed, as this hormone has been shown to increase
significantly the fractional excretion of urea (FEurea).
91–93 In
this context, it is interesting to observe that chronic glucagon
infusion in normal rats induced no change in the abundance
of UT-A1 and UT-B mRNA in the kidney but doubled the
abundance of UT-A2 mRNA in the inner stripe and the
upper IM.94 Moreover, studies in isolated rat IMCD showed
that the addition of glucagon to the medium decreased urea
reabsorption dose dependently (in microperfused IMCD)
and decreased UT-A1 expression (in IMCD suspensions).95
Glucagon has been shown to influence the expression of
the facilitated UTs. A chronic infusion of glucagon increases
the expression of UT-A2 mRNA in the inner stripe and the
upper IM (see above) and that of UT-A1 in the IMCD.95
Building the urea gradient vs. steady state. Urea secretion
in the pars recta and urea recirculation in the countercurrent
exchanger initiated by urea escape from the TDLs through
UT-A2 are probably especially important for the building of
the medullary urea gradient and restoring a high urine
osmolality after a period of water diuresis, which washed out
this gradient. This secretion and recirculation are probably
less important for maintaining the gradient in steady state,
once it is established. Recent findings in double UT-B and
UT-A2 KO mice support this interpretation.67 Invalidation of
UT-A2 in UT-B-deficient mice partially corrected the urine
concentrating defect seen in these mice and brought urine
osmolality to values close to those observed in wild-type mice,
even after water deprivation (Figure 4a). However, when
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Figure 3 |Abundance and localization of UT-A2 in the outer
medulla. (a) Northern blot showing the influence of urine
concentration on the abundance of UT-A2 mRNA in the inner
stripe and inner medulla of rats. To increase or reduce their
spontaneous urine osmolality, some rats received a chronic
infusion of dDAVP and others were offered their daily food
moderately or highly enriched with water in the form of an agar
gel (MWI and HWI, respectively). Reproduced with permission
from Trinh-Trang-Tan and Bankir.86 UT-A2 was present in the inner
stripe (IS) in all situations, whereas it was present in the inner
medulla (IM) only after normal or high V2 receptor stimulation (by
endogenous AVP or by dDAVP). (b) In situ localization of UT-A2
protein in the IS and in the upper IM of Brattleboro rats with
diabetes insipidus (DI), untreated (left) or treated chronically with
dDAVP. UT-A2 protein abundance was increased in the IS and
appeared in the upper IM under the influence of V2 stimulation
by dDAVP. Reproduced with permission from Wade et al.81
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Figure 4 | Effect of an acute urea load in wild-type mice and in
mice with deletion of either UT-B alone or UT-B and UT-A2.
Adapted from Lei et al.67 (a) Urine osmolality in basal condition
and after 18 h water deprivation. Mice with combined UT-B/UT-A2
KO concentrate urine almost as well as do wild-type mice in both
situations. (b) Urine osmolality and flow rate, and urinary
concentration of urea and non-urea solutes in conscious mice
before (time 0) and 2–10 h after an acute urea load. In the late
phase of the study (6–10 h), the concentration of non-urea solutes
rose progressively in the urine of the double KO mice, as in wild-
type mice, but that of urea did not. This suggests that UT-A2 has a
role in the progressive accumulation of urea in the inner medulla.
It also shows that urea accumulation is not a prerequisite for
accumulation of sodium chloride (the most abundant ‘non-urea
solute’) in the medulla. #, significantly different from UT-B KO
mice; *, significantly different from wild-type mice. KO, knockout.
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challenged with an acute urea load, it became obvious that
both urine osmolality and urine urea concentration could not
rise as much in the double KO mice as in wild-type mice. In
contrast, the concentration of all other solutes (‘non-urea
solutes’ calculated from the difference between urine osmol-
ality and urine urea concentration) rose to the same level as in
wild-type mice (Figure 4b). These observations suggest that
UT-A2 contributes to the accumulation of urea in the IM after
an acute challenge, but not in steady state,67 thus explaining
why single UT-A2 KO mice do not exhibit a urine
concentrating defect.17 It would be interesting to test whether
urine concentrating ability in UT-A2 KO mice would be
restored less rapidly after an acute episode of water diuresis, or
whether their urine osmolality would be improved after an
acute urea load, as performed in other mouse models.11,96
These results also confirm that the accumulation of NaCl
(which represent a large fraction of the ‘non-urea solutes’)
does not depend on the prior accumulation of urea, as already
deduced from observations in UT-A1/3 KO mice.23 In any
case, this hypothesis was not compatible with previous
observations in rats during water diuresis and in Brattleboro
rats with central diabetes insipidus, because in both cases a
near-normal NaCl concentration was observed in the IM in the
absence of any urea gradient.97–99
AQP1 is abundantly expressed along the entire proximal
tubule and accounts for most of the high water permeability
of this nephron segment. However, an additional aquaporin,
AQP7, is expressed only in the pars recta. This is an
aquaglyceroporin that, in addition to water, facilitates the
transmembrane transport of glycerol and urea. Mice lacking
AQP7 do not exhibit a urine concentrating defect and show
normal plasma urea level and normal urea concentration in
the IM.100 However, the selective expression of AQP7 in the
pars recta suggests that it could have a role in the dynamic
phase of restoration of the urea gradient after a period of
high diuresis. This hypothesis deserves to be explored in
experiments evaluating the time course of recovery of urine
concentrating ability and medullary urea concentration after
an acute water diuresis in AQP7 KO mice.
Observations supporting active urea secretion in the
pars recta
Direct evaluation of urea transport in isolated pars
recta. Because micropuncture experiments in rats showed a
net urea addition in the loops of Henle, two groups attempted,
several decades ago, to evaluate, by in vitro microperfusion
experiments, whether urea was secreted in the pars recta of
the proximal tubule. Both groups used rabbit tubules because
this was the only species in which microdissection and
microperfusion were possible in those early times. A very
modest but significant active urea secretion was observed in
the first study (using cortical and medullary pars recta),101
but this was not confirmed in the second study (using only
cortical pars recta).102 Although a recent study suggests that
urea secretion could occur in the rabbit kidney,103 it seems
clear that this animal is not the best-suited species for
demonstrating this secretion because of its protein-poor diet,
making urea-nitrogen conservation far more important than
efficient urea excretion. To our knowledge, no attempt has
been made to evaluate in vitro a possible active urea secretion
in isolated perfused pars recta of rats, mice, or other
mammals.
Familial azotemia without renal failure. Unexplained high
plasma urea concentration (Purea) in the absence of any other
sign of renal dysfunction has been occasionally reported in a
few human families. Three different papers described in detail
such cases of familial azotemia without renal failure.104–106
The phenotype consists in a three- to fourfold elevation in
Purea due to a markedly decreased FEurea. Interestingly, the
sensitivity of FEurea to urine flow rate in these subjects exactly
paralleled that in healthy individuals, but was largely shifted
down (Figure 5). This suggests that the vasopressin-
dependent influence on FEurea, due to flow-dependent
reabsorption in the distal nephron and CD, is unaltered in
these subjects. The defect was attributed to an excessive urea
reabsorption in the pars recta of the proximal tubule, but an
editorial accompanying one of these studies suggested that it
might be due to a genetic anomaly that interferes with urea
secretion in the pars recta.107
At present, familial azotemia could adequately be explained
by a loss-of-function mutation in the transporter responsible
for this active urea secretion. The observations reported in
these patients provide a mean to quantify the magnitude of
this secretion. Comparison with healthy subjects in the same
study shows that urea secretion is responsible for the excretion
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Figure 5 |Urea handling in normal subjects and subjects with
familial azotemia. In normal subjects, the fractional excretion of
urea (FEurea) is relatively high at high urine flows but decreases
with declining urine flow and varies around 40% for urine flows
within the normal range. This fall in FEurea at reduced urine flows
is due to urea reabsorption in the collecting duct that increases
with a longer contact time and is favored by the direct action of
vasopressin on UT-A1/3/4. In subjects with familial azotemia, the
handling of urea in the collecting duct seems to be normal, as the
usual flow-dependent decline in FEurea is observed, but the whole
relationship is shifted toward lower values. This reduces FEurea to
one-third of normal for urine flows within the normal range. The
difference between the two situations may be accounted for
by a lack of urea secretion in patients with familial azotemia.
Adapted from Bankir and Trinh-Trang-Tan.7
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of about half of the excreted urea in water diuresis, and even
more at urine flows falling in the physiological range
(Figure 5). Such a large urea secretion is fully compatible
with an extraction of less than half of the urea entering the
medulla via the efferent arterioles of juxtamedullary glomer-
uli, as explained elsewhere (page 681 in the article by Bankir
and Trinh-Trang-Tan7).
Familial azotemia could also result from the dysfunction of
other urea transporters. (1) A loss of function of a putative
active urea transporter expressed in the bladder urothelium
(see further) could also explain a selective rise in plasma urea
in the absence of renal dysfunction. (2) Theoretically, a
reduced efficiency of countercurrent exchange between
ascending and descending vasa recta due to a loss of function
of UT-B should result in a greater return of urea through
venous blood into the peripheral circulation and a higher
Purea. This is the case in UT-B KO mice,
11,16 which show a
Purea-value 50% higher than that of wild-type mice. This
difference is much more modest than the threefold difference
seen in humans with familial azotemia. Moreover, blood urea
nitrogen is not significantly altered in UT-B-deficient
subjects.108 This species difference in phenotype between
UT-B-deficient mice and humans probably reflects the fact
that countercurrent urea exchange between ascending and
descending vasa recta is much less important in humans than
in mice, because of their much lower urine concentrating
ability and much shorter relative length of the IM.22
High fractional excretion of urea observed in some situa-
tions. Because about 50% of the filtered urea is invariably
reabsorbed in the proximal convoluted tubule19,55,56,59,78,109,110
and escapes the kidney through the venous cortical blood flow,
at least 50% of filtered urea cannot be excreted in final urine.
Accordingly, values of FEurea above 50%—not 100% as often
believed—reveal net urea secretion. Table 1 lists several reports
in which FEurea was found to exceed 50% (and even
occasionally 100%) in humans, dogs, or rats, either in basal
conditions or after a single meat meal, a high-protein diet for a
few days, or specific experimental maneuvers such as increases
in diuresis, or infusion of glucagon (Table 1). Other situations
in which high FEurea was observed include water diur-
esis,84,118,119 saline diuresis,120 chronic renal failure,121,122 sickle
cell anemia,113,123 or infusion of prostaglandins124,125 or
glucocorticoids.93 The low Purea and high FEurea observed in
sickle cell disease may be due to a more efficient urea secretion
in the pars recta probably favored by the longer transit time of
sickled red cells in outer medullary vasa recta. FEurea exceeding
100% was observed in rats and dogs during intense osmotic
diuresis,120,126 after providing hyperosmotic urea as sole
Table 1 | Studies in which fractional excretion of urea was increased by various protocols and reached values exceeding 0.50
Intervention and condition A and B
Index of GFR
Urine collection
FEurea
Condition A
FEurea
Condition B Statistical significance Reference
Humans
Increase in diuresis
A=low; B=high (after water load)
Inulin 0.32 0.69 104
Single protein meal
A=before; B=1–2h after the meal
Inulin 0.60 0.73 Po0.001 111
Pyrazinoylguanidine (3 days)
A=before; B=during treatment
Creatinine 0.45±0.12 0.67±0.16 Po0.001 112
Sickle cell anemia
A=healthy subjects; B=sickle cell patients
Inulin 0.59 0.68 Po0.05 113
Dehydration in three patients with central DI
A=control; B=dehydrated
Creatinine 0.47, 0.60, 0.56 1.65, 1.10, 1.28 114
Dogs
Meat meal (24 experiments in 3 dogs) (N)
A=Before the meal; B=4 h After the meal
Creatinine 0.44±0.03 0.57±0.02 Po0.001 115
Rats
Change in salt and protein Intake (N)
A=normal; B=high protein and NaCl diet
Inulin 0.55 0.80 116
Hypertonic urea infusion (GA)
A=control; B=during infusion
Inulin 0.37±0.04 0.67±0.02 Po0.001 21
Change in protein intake (N)
A=low protein; B=high protein
Creatinine
24-h urine
0.60±0.07 1.26±0.05 Po0.001 117
Change in urine flow rate (1 week) (N)
A=low (dDAVP); B=high (hydrated food)
Inulin
24-h urine
0.43±0.02 1.18±0.18 Po0.001 84
Mice
UT-A1/3/4 KO on high-protein diet (N)
A=wild type; B=UT-A1/3/4 KO
Inulin
24-h urine
0.68±0.05 1.02±0.09 Po0.05 23
UT-B/UT-A2 KO (N)
A=wild type; B=UT-B/UT-A2 KO
Creatinine
24-h urine
2.00±0.10 1.50±0.10 Po0.05 67
Abbreviations: FE, fractional excretion; GA, glycine-alanine; GFR, glomerular filtration rate; KO, knockout.
All values of FEurea 40.50 are shown in bold. For animal studies: N, no anesthesia.
UT-A1/3/4 KO: mice with KO of UT-A1, UT-A3, and UT-A4. UT-B/UT-A2 KO: mice with KO of UT-B and UT-A2.
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drinking fluid,21 or after the combination of high protein and
high salt intake.116 Other situations with FEurea higher than
50% are shown in Table 1.111,112,114,115
During an episode of dehydration in normal subjects, a
fall in FEurea and a rise in serum urea were observed, as
expected from the known action of vasopressin on urea
reabsorption in the CD. In contrast, in patients with diabetes
insipidus, dehydration induced changes in the opposite
direction: FEurea rose above 100% and serum urea fell
markedly.117 This high FEurea observed in the absence of
vasopressin suggests that urea is abundantly secreted in the
nephron but that, in healthy subjects, this secretion is
largely compensated by a strong vasopressin-dependent urea
reabsorption.
Recent studies in mice suggests that FEurea is higher in this
species than in other mammals and could even exceed 100%,
whether filtration rate is evaluated by inulin23 or creatinine
clearance, with a reliable creatinine assay (Table 1).11,67 As
explained elsewhere, this high FEurea in mice is probably
related to the huge turnover of urea that imposes on the
kidney a considerably larger load of urea to excrete, because
of the more intense metabolism and much greater food
intake per unit body weight observed in smaller animals.22
FEurea can be altered pharmacologically by pyrazinoylgua-
nidine (a drug that shares some homology with pyrazina-
mide, an inhibitor of urate secretion). This drug increased
the urea/creatinine clearance ratio in mongrel dogs and
Dalmatian coach hounds.18 In patients with chronic renal
failure, oral treatment with pyrazinoylguanidine for 3 days
increased the urea/creatinine clearance ratio from 0.45±0.12
to 0.67±0.16 (Po0.001).112 Stop-flow experiments in dogs
showed that urea secretion, inhibitable by pyrazinoylguani-
dine and analogs, probably occurs in the most distal portion
of the proximal tubule.127
Consequences of impaired pars recta function. Cisplatin, an
antineoplastic drug, is known to be nephrotoxic and to
impair the urine concentrating ability. Pathological changes
are localized to the S3 segment of the proximal tubule in the
outer stripe.128,129 Safirstein et al.130 described in detail the
renal handling of the different solutes and the urine
concentrating defect observed in rats 3 days after cisplatin
administration.130 Purea rose about threefold. Solute concen-
trations in the renal medulla were markedly reduced, but that
of urea was reduced to a much greater extent than that of
sodium, suggesting a selective defect in medullary urea
accumulation. Although urine flow rate was markedly
increased, FEurea decreased (a change opposite to what is
usually observed). Micropuncture studies in the late proximal
and early distal tubule on the surface of the renal cortex of
control and cisplatin-treated rats allowed the evaluation of
solute movements in the loops of Henle of superficial
nephrons. The fraction of filtered urea delivered to the late
convoluted proximal tubule was closely comparable in the
two groups. However, as shown in Figure 6, the usual net
addition of urea, known to occur in the loop of Henle, was
observed only in control rats, whereas net urea reabsorption
was found in cisplatin-treated rats.130 These results indicate
that the pars recta is responsible for the urea addition
observed in control rats and that cisplatin-induced damage
impaired this secretion. Cisplatin administration in dogs lead
to similar observations. Purea rose 3-fold, whereas plasma
creatinine was increased by only 1.8-fold,131 suggesting a
marked fall in FEurea, likely due to impaired secretion by the
damaged pars recta, as shown in rats.
The data provided in the micropuncture study of
Safirstein et al.130 allow a quantitative evaluation of the
magnitude of urea secretion in rats. In controls, the net
addition of urea between the late proximal and early distal
tubule of a punctured superficial nephron was 127 pmol/min,
whereas the net urea reabsorption in a nephron of cisplatin-
treated rat was 157 pmol/min. Thus, the total amount of urea
secreted per superficial nephron in control rats should
amount 127þ 157¼ 284 pmol/min. Urea secretion in juxta-
medullary nephrons is likely even higher because of the
tortuous course of their pars recta that lengthens the contact
area with ascending vasa recta in the inner stripe. Factoring
284 pmol/min by 30,000 nephrons per kidney suggests that
pars recta in one kidney of control rats secreted urea at a rate
of about 8.5 mmol/min, a value close to that of glomerular
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Figure 6 | Influence of cisplatin on urea handling in the loop of
Henle. Results obtained during micropuncture study in control
rats and rats treated previously with cisplatin, a drug that impairs
the function of the pars recta. Lines represent the calculated
difference between the rate of urea delivered to the early distal
tubule and that measured in the late proximal tubule in the same
nephron. In control rats (dotted lines, n¼ 30 nephrons), significant
amounts of urea are added to the loop of Henle, whereas in
cisplatin-treated rats (continuous lines) there is a net reabsorption
of urea (n¼ 19 nephrons). This (passive) reabsorption probably
also occurs in control rats and is overriden by a higher urea
secretion. It may thus be assumed that urea secretion amounts to
157þ 127¼ 284 pmol/min per nephron and 8.5mmol/min per
kidney (assuming 30,000 nephrons per kidney, with similar
secretory capacity). Adapted from Safirstein et al.130
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urea filtration (9.8 mmol/min). These results indicate that, in
rats, urea secretion probably contributes to about half of the
urea excreted in the urine. Interestingly, this is also the
conclusion drawn from comparison between healthy subjects
and subjects with familial azotemia (see above). This is fully
compatible with the fact that medullary blood flow, issued
from postglomerular blood of the juxtamedullary glomeruli,
carries in plasma and erythrocytes more urea than that
delivered by the glomerular filtrate to the pars recta (see
calculations in Table 2).
Cyanide is a drug that induces a reversible inhibition of
oxidative metabolism. Elegant studies conducted in dogs by
in situ kidney perfusion showed that, after infusion of
cyanide in the left renal artery, urea clearance decreased
dramatically to 1/10 of the previous value, in spite of a
marked rise in urine flow rate and unchanged inulin and
creatinine clearances. The right vehicle-infused kidney
showed no change.132 The author, in 1949, assumed that
kidney cells have ‘to perform work involving the use of
enzyme systems, inhibited by cyanide, to prevent urea from
diffusing back from the concentrated tubular urine’. In the
light of our present knowledge, the fall in urea clearance, in
spite of a marked increase in urine flow rate (which usually
increases urea clearance), may be best explained by an
inhibition of active urea secretion in the pars recta.
Acute renal failure may depend on either prerenal
hemodynamic factors or on acute tubular necrosis. Several
studies have shown that values of Purea, FEurea, or the ratio of
urine-to-plasma urea concentration (U/P ratio) can be used
to differentiate these two conditions.133–135 In the case of
acute tubular necrosis, the U/P urea ratio is largely reduced
and Purea rises significantly more than does plasma creatinine
concentration. This may be easily explained by an inability of
the damaged pars recta to secrete urea, thus resulting in a
greater reduction in urea clearance than in creatinine
clearance, the latter being sensitive only to the reduction in
glomerular filtration rate.
Species differences in renal urea handling
In studies conducted several decades ago, Schmidt-Nielsen136
had already proposed that urea excretion was regulated
because FEurea could vary largely with changes in the protein
content of the diet, especially in ruminants.136 Actually,
marked differences in urea handling are observed in different
mammalian groups in relation to their widely different
natural diets and habits. Renal urea reabsorption takes place
especially in herbivores for the purpose of nitrogen conserva-
tion, whereas renal urea secretion might be more intense in
carnivores that eat a protein-rich diet and consume large
amounts at distant intervals. Interestingly, urea permeability
in red cells (which also express UT-B) also differs according to
the diet in different groups of mammals, being far higher in
carnivores than in herbivores and intermediate in humans,
pigs, and rodents.137
In sheep (and probably other ruminants), FEurea can fall to
extremely low levels when their protein intake is strongly
restricted.138,139 This can be explained by the active urea
reabsorption that has been characterized in the initial
IMCD39,43,140 in rats fed a low-protein diet for several
weeks. The reabsorbed urea is then broken down by
urease-possessing bacteria in the rumen (in ruminants) or
colon (in other mammals), and the nitrogen can be reused
by the mammalian organism.7 Urea accesses the rumen or
colon lumen by facilitated UTs that share homology with
those expressed in the kidney.35,36
In carnivores, the kidney exhibits a specialized ‘S4’
segment in the proximal tubule (in addition to the classical
S1, S2, and S3 segments) with anatomical features suggesting
solute secretion rather than solute reabsorption.141 This
observation could explain why dogs are able to excrete much
more urea per gram kidney mass than other mammals.142
Small rodents in which high FEurea has been reported may
also exhibit intense urea secretion because of their high food
intake associated with their high metabolic rate linked to
their small size.22 In other mammals including humans, this
secretion most likely also occurs, as suggested by familial
azotemia without renal failure (see above), even if it is more
difficult to demonstrate.
Table 2 | Quantitative aspects related to urea filtration and
secretion
The gross calculations below show that the amount of urea potentially
available for secretion from the vasa recta into the pars recta is quite
significant compared to luminal urea issued from filtration and urea issued
from recycling from the collecting duct.
Amount of urea flowing in vasa recta blood (issued from efferent arterioles
of juxtamedullary glomeruli) and available for uptake in case of active
pumping from surrounding cells.
Vasa recta urea=15% of urea in renal blood flow (RBF), assuming that
medullary blood flow is 15% of total RBF. Note that both urea in plasma
and red cells is available for rapid use because red cells express the
facilitated urea transporter UT-B.
Amount of urea flowing in the pars recta lumen of all nephrons.
Pars recta urea=urea in RBF 0.55 (if hematocrit=45%) 0.25 (if filtration
fraction is 25%) 0.50 (if half of the urea is reabsorbed in the convoluted
proximal tubule)=7% of the urea present in the blood perfusing the whole
kidney.
Amount of urea possibly added to ascending vasa recta blood as a result of
urea delivery at the tip of the papilla by UT-A1 in the terminal inner
medullary CD.
Fractional urea excretion in antidiuresis is about 30–40%. Assuming that
half of the urea is recycled through UT-A1 instead of being excreted
means that o20% of the filtered urea can be returned in the ascending
vasa recta, i.e., about 7%. And less than that should reach the outer stripe
and be available for secretion because of countercurrent exchange with
descending vasa recta in the inner medulla and inner stripe of outer
medulla.
Amount of urea produced locally by hydrolysis of arginine.
The pars recta can hydrolyze arginine into urea plus ornithine. But the
arginine supply in this area is relatively low because arginine
concentration in the blood is only about 200mmol/l. Thus, the ability to
form urea in the pars recta is probably relatively modest. But it may have a
significant contribution in some situations, or if unknown pathways can
bring to the pars recta some arginine produced in the convoluted part of
the proximal tubule.
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Role of glucagon in the regulation of urea excretion
Within a given species, urea excretion is probably selectively
stimulated after a protein meal, as suggested by elegant
studies in dogs. O’Connor and Summerill115 showed that
FEurea increased markedly 4 h after a regular meat meal,
whereas it did not change when an equivalent load of urea
was given by means of a stomach tube (Figure 7a and b, left).
Ingestion of proteins is known to stimulate glucagon
secretion, and glucagon is a potent stimulus of ureagenesis
in the liver.143–149 This hormone is considered to have a
major role in the disposal of nitrogen wastes.150,151 Moreover,
in the face of this increased solute load, it contributes to
water economy. Studies in anesthetized rats have shown that
glucagon infusion increases medullary hypertonicity,152 urine
concentration,153 and solute-free water reabsorption, along
with an increase in urea excretion.91
Glucagon has also been shown to increase FEurea (Figure 7b,
right), thus demonstrating a tubular action independent of,
and additive to, its influence on glomerular filtration
rate.91,92,154 Glucagon could improve the efficiency of urea
excretion by stimulating active urea secretion. An action of
glucagon in the pars recta is strongly suggested by micro-
puncture studies in rats.155 This action could possibly be
mediated by specific receptors156 that would not be coupled to
adenylate cyclase, contrary to those located in the distal
nephron.157 Alternatively, this stimulation could also be
induced by circulating, extracellular cAMP originating from
the liver under the influence of glucagon, as suggested
previously.158 In addition, glucagon has been shown to
influence the expression of the facilitated UTs (see above).
See Notes added in proof (Note 1).
POSSIBLE LINKS BETWEEN UREA AND GLUCOSE HANDLING
Given the multiple studies that support the existence of an
active urea secretion in the mammalian kidney, it is
surprising that the transporter responsible for this secretion
has not yet been identified. As recalled above, active urea
uptake has been characterized in unicellular organisms and
plants, but no homology with any of the corresponding active
urea transporters has been found in the mammalian genome.
Actually, the transporter secreting urea in the pars recta may
have been cloned already but thought to have another
function, as has recently been the case for the protein
encoded by the gene SLC2A9. This membrane protein,
initially identified as a facilitated glucose/fructose transporter
(GLUT9), has now been shown to be, in fact, a uric acid
transporter.159,160 Genetic variants or experimental inactiva-
tion of this gene are associated with reduced urinary urate
clearance and increased serum urate concentration, suggest-
ing impaired urate secretion.161,162 Interestingly, a secondary
active, Na-coupled, glucose transporter, SGLT1, which is
abundantly expressed in the mammalian pars recta, has been
shown to transport also urea.163,164 Thus, obviously, some
membrane proteins involved in sugar transport (GLUT9 and
SGLTs) can also transport nitrogen wastes such as uric acid
and urea, respectively.
Actually, the fate of glucose and that of urea are often
linked. In the liver, gluconeogenesis and ureagenesis are
always associated165 so as to dispose of the nitrogen atoms
of the amino acids used for gluconeogenesis, whether these
amino acids come from the food or from endogenous stores
(during fasting).7,150,151 Glucagon, the hormone that pro-
motes glucose formation, is also a potent stimulus for urea
synthesis by the liver, as mentioned above.149,166 In the kidney,
the nephron subsegment where urea is probably secreted is also
involved in both gluconeogenesis (from various substrates)
and formation of urea (by hydrolysis of arginine).167 It is
tempting to assume that glucagon could promote simulta-
neously gluconeogenesis,168 urea formation,169 and urea
secretion in the pars recta. See Notes added in proof (Note 1).
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Figure 7 |Acute regulation of urea excretion. (a) Relationship
between urea excretion and plasma urea concentration in the
same dog studied either in control conditions (crosses), after a
meat meal (closed circles), or after an infusion of urea bringing the
same amount of nitrogen (open circles; 8–10 experiments in each
condition). The influence of the protein meal clearly differed from
that of the urea infusion. Reproduced with permission from
O’Connor and Summerill.115 (b) Left: influence of a protein meal
on FEurea in three dogs (mean of 8–10 experiments per dog).
Drawn after O’Connor and Summerill.115 Right: influence of an
acute infusion of glucagon (solid line) or vehicle (dotted line) in
anesthetized rats. Drawn after Ahloulay et al.91 (a), and Knepper
et al.154 (b). Both the meat meal and the infusion of glucagon
increased FEurea by about 30%.
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Although the pars recta shares a number of characteristics
with the convoluted part of the proximal tubule, it exhibits
several anatomical and functional features that make this
segment quite different (Table 3). Its vascular blood supply is
different (Figure 2), and it expresses a few additional enzymes
(arginase167) and transporters not present in the earlier
portion of the proximal tubule, namely SGLT1 (see below)
and AQP7 (a urea-permeable aquaporin).100
Could SGLT1 be involved in urea secretion?
Two different secondary active, sodium-dependent glucose
transporters are expressed in the luminal membrane of the
proximal tubule, SGLT1 and SGLT2. However, their localiza-
tion along this nephron segment, their affinity for glucose,
and their stoichiometry are different.170 SGLT2 is expressed
in most of the proximal tubule. In contrast, SGLT1 is
restricted to the pars recta, and its expression is the highest in
the outer stripe,171 as shown in Figure 8. SGLT1 has a higher
affinity for glucose than SGLT2; it transports one molecule of
sugar along with two Na, whereas SGLT2 transports one
sugar with one Na.
Transport studies in amphibian oocytes expressing SGLT1
have shown that this cotransporter can also transport urea in
two independent ways. First, besides the sites involved in the
coupled glucose and sodium transport, this highly complex
membrane protein (over 650 amino acids and 14 transmem-
brane domains) exhibits a urea channel that allows urea and
water to diffuse along their concentration gradient, a process
that is inhibitable by phloretin. Second, urea is also
transported uphill when the cotransporter is activated by
the presence of sugar, and the rate of sugar-dependent urea
uptake is directly proportional to the rate of Naþ–glucose–-
H2O cotransport and is inhibited by phlorizin.
163 Interest-
ingly, Sce-DUR3, the active urea transporter identified in
yeast, and the different mammalian SGLTs belong to the same
cotranporter family SLC5.172 This observation further
supports the concept of a significant link between urea and
glucose through evolution.
It is usually assumed that SGLT1 contributes to reabsorb
the small amount of glucose that remains in the lumen of the
pars recta after most of the filtered glucose has been
reabsorbed upstream through SGLT2. This is confirmed by
recent observations in SGLT1 KO mice.173 Not often
mentioned is the fact that glucose concentration within the
cells of the pars recta may be relatively higher than in other
cells because of intense local gluconeogenesis (see further).
SGLT1 can work in both directions, depending on the ligand
concentration on each side of the membrane.174 Thus, it is
possible to assume that SGLT1 might transport some glucose
from the cell cytoplasm into the lumen, especially in the long
loops, and preferentially so at certain times of the diurnal
Table 3 | Specific metabolic pathways and membrane
proteins in the medullary pars recta and specific
environment in the outer stripe of the outer medulla
Metabolic pathways
Gluconeogenesis (preferentially from lactate) that may result in
increased intracellular glucose concentration.
Urea formation (+ ornithine) from arginine hydrolysis by arginase
(arginine taken up from the basolateral side of the cells) that may result
in increased intracellular urea concentration.
(many other metabolic pathways not mentioned here, e.g.,
ammoniogenesis)
Membrane transporters
SGLT1 Sodium-glucose transporter, also transporting urea
AQP7 Aquaglyceroporin also permeable to urea
(many other transporters not mentioned here, e.g., NaPi, organic anion
transporter, and so on)
Membrane receptors
Glucagon or cAMP receptors? Possible regulation either directly through
glucagon or through extracellular cAMP released in the blood by the
liver under the influence of glucagon?
(many other receptors not mentioned here, e.g., parathyroid hormone
receptor)
Environment
Almost no significant direct arterial blood supply (scarce branching of the
efferent arterioles of deep glomeruli).
Blood supply comes mainly from wide numerous ascending venous vasa
recta (AVR). These vasa recta ascend from the inner medulla through
vascular bundles in inner stripe of the outer medulla, allowing intense
countercurrent exchange. Blood velocity is low in these AVR because
their cross-sectional area is far greater than that of corresponding
descending vasa recta. Moreover, there is a large surface area of contact
between pars recta and these AVR. Both this long contact time
and large contact area favor transmembrane transport along the
peritubular side of pars recta cells.
Secretion
The pars recta is known to secrete a number of organic molecules (uric
acid, hippurate, cyclic nucleotides, and so on) and xenobiotics.
These molecules are extracted from ascending vasa recta blood that is
issued from the efferent blood of juxtamedullary glomeruli and has
flown through the outer and inner medulla before flowing around the
pars recta.
The secretory activity of the pars recta probably exceeds its reabsorptive
activity. Water follows the secreted solutes because the pars recta is
freely permeable to water. This means that a net addition of fluid and
solutes is likely to occur in this nephron segment.
CO
MR
OSOMG
G*
ISOM
Figure 8 | Localization of SGLT1 in the rat kidney. In situ
hybridization of SGLT1 showing that it is localized to the
medullary rays (MR) of the cortex (CO) and in the outer stripe
(OSOM) but not in the inner stripe (ISOM) of the outer medulla,
a localization corresponding to the pars recta of the proximal
tubule. Reproduced with permission from Lee et al.177
*, blood vessel. G, glomeruli.
1190 Kidney International (2012) 81, 1179–1198
rev iew L Bankir and B Yang: New insights into renal urea and glucose handling
cycle. In other words, it is conceivable that some glucose may
undergo secondary active, sodium-dependent secretion in the
pars recta and that some urea may be cotransported along
with glucose, as has been demonstrated in oocyte experi-
ments.164 The fate of the secreted glucose will be discussed in
the next section.
Could gluconeogenesis in the pars recta contribute
to urine concentration?
The whole proximal tubule is able to perform gluconeogen-
esis from various substrates. Some studies however suggest
that, in usual conditions, the S3 subsegment is involved more
strongly in this metabolic pathway than S1 and S2
subsegments.175,176 Moreover, PEPCK, the enzyme that is
the limiting factor for gluconeogenesis, and/or its mRNA are
more abundantly expressed in the pars recta than in the
convoluted part of the proximal tubule.175,177 Lactate appears
to be the preferred substrate for gluconeogenesis in this part
of the nephron in several species including humans.178–180
Why would the S3 segment extract substrates from the
peritubular blood and spend six ATP molecules per newly
formed glucose in the OM when so much more glucose can
be synthetized in the liver? Could this renal-borne glucose
serve some function in the kidney itself? Instead of being
released in peripheral blood, this glucose might be secreted
into the lumen and be carried through the thin limbs down to
the inner stripe of the OM, and the IM (through the short-
looped and the long-looped nephrons, respectively). In the
inner stripe, renal-borne glucose could be used as fuel in
the medullary thick ascending limbs, assuming that glucose
can be taken up by these cells through their luminal
membrane. In the IM, this renal-borne glucose may
contribute to the urine concentrating mechanism in several
ways as described below.
Countercurrent exchange of oxygen between arterial
(descending) and venous (ascending) vasa recta limits oxygen
delivery to the IM. In this kidney region, anaerobic glycolysis
is used to provide energy. Lactate formed during this process
is distributed along a distinct corticomedullary concentration
gradient, qualitatively similar to the gradient known to occur
for sodium and chloride.181 Part of the lactate is trapped
locally by countercurrent exchange between venous (ascend-
ing) and arterial (descending) vasa recta, so that lactate
concentration at the tip of the papilla reaches values four- to
sixfold higher than in the cortex.181,182 It has been proposed
that anaerobic glycolysis, forming two lactate molecules from
one glucose, could contribute to increase interstitial medul-
lary osmolality in two ways: first, by providing two ATP
molecules per glucose to support the metabolism, and,
second, by generating two osmoles out of one, thus resulting
in a ‘single osmotic effect’ that helps drive water from the
surrounding structures. Two independent mathematical
models have shown the benefit of this process on
urine concentration.183–185 The most elaborate model,183
although not integrating the three-dimensional architecture
of the IM illustrated in more recent studies,186 and simulating
nephrons and vessels as single tubes, shows that the convers-
ion of as little as 15% of the medullary blood glucose into
lactate improves urine osmolality at the tip of the papilla by
about 600mosm/l, an effect mostly accounted for by
accumulation of NaCl.183
This model,183 as well as that of Zhang and Edwards,185
assumed that glucose used in the IM was coming from the
blood perfusing the IM through descending vasa recta. We
propose that glucose available for conversion into lactate
could originate from gluconeogenesis in the pars recta and be
delivered directly to the IM via the descending limbs of
Henle. Some studies have identified glucose transport in the
TDLs of short loops of Henle, possibly along with urea.187 It
is conceivable that a similar transport exists also in long
loops. Even if the number of long loops decreases
progressively along the IM,186 this pathway could ensure a
functionally significant additional glucose delivery to this
region because the luminal glucose, added upstream by an
active secretion, would be several fold more concentrated
than that present in the descending vasa recta.
Nephrogenic glycosuria in the absence of hyperglyce-
mia,188 observed in rare circumstances, could, at least in
some cases, be due to the failure of secreted glucose to be
broken down into lactate when flowing through the IM, and/
or to be taken up by the thick ascending limbs.
Could an intrarenal Cori cycle allow the conversion of
chemical energy spent in the outer stripe into osmotic energy
carried to the IM?
Because ascending vasa recta are highly fenestrated, the
medullary interstitium is always equilibrated with vasa recta
blood. As a result, lactate, accumulated in the IM as
explained above, should, similar to all other medullary
solutes, be continuously taken up by ascending vasa recta and
returned to the arcuate veins at the corticomedullary border
and back to the general circulation. However, in the outer
stripe, some of this lactate can be taken up by the proximal
tubule pars recta to serve as a substrate for gluconeogenesis.
As recalled earlier, the anatomical arrangement of vessels and
tubules in the outer stripe favors a close contact between
ascending vasa recta and descending pars recta,1,62,64,65
especially those of long loops that exhibit a tortuous course
that increases S3 epithelium abundance.
The reuse of lactate for gluconeogenesis in the outer stripe
after glucose breakdown into lactate in the IM forms an
intrarenal Cori cycle (Figure 9). The traditional Cori cycle
operates between liver and extrahepatic tissues such as
muscles. Glucose is used in these tissues to provide energy
through glycolysis, and the resulting lactate diffuses into the
blood stream, is reconverted into glucose in the liver, and can
be resupplied to extrahepatic tissues. This cycle consumes six
ATPs for gluconeogenesis and releases two ATPs during
glycolysis. The net cost is thus four ATPs. This cycle has been
reported to occur within the rat kidney studied in vitro.189 If
such a glucose–lactate–glucose cycling occurs within the
kidney, it will allow the conversion of chemical energy spent
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in the upper part of the OM, still relatively well oxygenated
(lying close to the arcuate arteries), into metabolic plus osmotic
energy (two ATPs plus two osmoles) delivered to the deep IM.
This hypothesis is attractive because it fits well with the
facts that PEPCK is most abundant in the S3 segment, that
lactate is the preferred substrate for gluconeogenesis in the
pars recta, that lactate is abundant in the IM, and that vasa
recta issued from the IM supply nutrient blood to the OM
pars recta (Figure 2). Further studies are needed to evaluate
whether this hypothesis holds true. The mathematical model
that has evaluated the contribution of anaerobic glycolysis to
urine concentration183 could probably be adapted to simulate
the reuse of lactate from ascending vasa recta to pars recta,
local gluconeogenesis, and subsequent delivery of glucose to
the IM via the long descending thin limbs.
DOES ACTIVE UREA REABSORPTION IN THE LOWER
URINARY TRACT CONTRIBUTE TO MAINTAIN HIGH UREA
CONCENTRATION IN THE URINE?
As recalled earlier, urea concentration in the urine may be a
100-fold higher than in plasma and extracellular fluids in
humans, and even more in rodents. Even without expressing a
facilitated UT, all cell membranes are permeable to urea to
some extent. If a marked transepithelial difference in urea
concentration is present, urea concentration will equilibrate
across an epithelium within minutes to an hour instead of
seconds when a facilitated UT protein is present. In the kidney,
the expression of epithelial UTs is limited to short portions of
the thin limbs and IMCDs, allowing rapid movements of only
limited amounts of urea between well-defined juxtaposed
tubular and/or vascular structures. In contrast, after urine exits
the kidney, it flows and/or stays for hours in structures that all
abundantly express UT-B (as well as AQP3) in the basolateral
membrane of their urothelium, including the pelvic wall,
ureter, and bladder,190,191 which are in permanent contact with
surrounding extracellular fluids iso-osmotic with plasma. Why
UT-B is expressed in these structures is not yet understood,
and the experiments conducted so far in UT-B-null mice have
not contributed information on this matter. See Notes added
in proof (Note 2).
Urothelium umbrella cells exhibit a unique morphology
that is assumed to contribute to their ability to prevent back
diffusion of concentrated solutes into the extracellular space.
Nevertheless, it is intriguing that a facilitated UT is
abundantly expressed in structures that need to maintain a
very high transepithelial urea concentration difference, thus
leaving the luminal membrane as the only barrier between
urine and the body’s extracellular fluids. The presence of UT-
B in the basolateral membrane of the urothelium makes more
sense if one assumes that an active (or secondary active) urea
transporter is expressed on the luminal side, permanently
reclaiming urea that would be at risk of escaping the bladder.
Thus, it seems reasonable to hypothesize that the ureter and
bladder are equipped with an active urea transporter that
reabsorbs urea. This transporter probably has a high affinity and
a low capacity, and could be homologous to the transporters
that have been functionally characterized (but not identified) in
the elasmobranch gills26 and in the ventral skin of some
toads.27–32,192 It is probably different from the transporter
expressed in the upper IMCD, which initiates the urea-nitrogen
salvage in ruminants and low protein-fed rats (see above) and
from the transporter that is responsible for urea secretion in the
pars recta (see above). These latter two transporters probably
have a lower affinity and a higher capacity.
As in many studies of transepithelial transport, the small
urea leakage observed in the ureter193 or bladder,194 may be
the net result of two opposite movements almost compensat-
ing each other, including a passive escape and a partial active
recovery. During bladder infections, the bladder becomes
permeable to solutes.195–197 This could partly result from a
significant downregulation of several transporters including
this active urea transporter. The same may be true in
Lactate uptake for
gluconeogenesis
Lactate
going up
in AVR
Glucose
going down
in long TDL
Glucose release
and hydrolysis
into two lactates
Figure 9 | Intrarenal Cori cycle. The Cori cycle consists of the
breakdown of one glucose into two lactates plus two ATPs, and
the resynthesis of one glucose from two lactates, requiring six
ATPs. The net energetic cost of this cycle is four ATPs. In the
kidney, we propose that glucose (formed by gluconeogenesis in
the pars recta) is secreted in the tubule lumen and flows down to
the inner medulla where it can diffuse into the interstitium and be
broken down into two lactates, thus increasing the osmolality of
the inner medulla. Ascending vasa recta (AVR) take up this lactate,
which can then, in part, return to the inner medulla by
countercurrent exchange with the descending vasa recta. Some
lactate, remaining in the ascending vasa recta in the outer stripe,
can be taken up by the pars recta and used again as a substrate
for gluconeogenesis. TDL, thin descending limb.
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hibernating bears.198,199 Nitrogen conservation during hiber-
nation is ensured by a permanent recycling of urea-nitrogen
between the bladder (which becomes permeable to urea) and
the digestive tract where urea can be degraded by bacteria
and its nitrogen reused by their host, as in herbivores.35,36
Interestingly, in rats, a small but significant active Na-
dependent, phloretin-insensitive urea secretion has been
observed in the deepest subsegment of the IMCD (i.e., along
a much shorter length than that expressing UT-A1/3).46
Because of the very small number of CDs remaining at the tip
of the papilla, and of the very short length of CD in which it
occurs, this active transport can add only very small amounts
of urea in the CD lumen. Moreover, the high UT-A1/3-
mediated urea permeability of these ducts and the direction
of the transepithelial difference in urea concentration in this
region should induce all the secreted urea to diffuse back into
the medullary interstitium. This active urea secretion in the
very terminal portion of the IMCD is thus puzzling. We
assume it could be the early manifestation of an active
transport that extends further down along the urothelium of
the pelvis, ureter, and bladder, and contributes to prevent the
dissipation of the urine-to-blood urea gradient in the lower
urinary tract. This hypothesis requires further investigation.
CONCLUSIONS
In the past few decades, the handling of urea in the kidney
has been largely neglected, and few clinical or experimental
studies now report data about urea, although this solute
represents about 40% of all urinary solutes in normal human
urine. Most recent renal textbooks include chapters on water
and electrolyte physiology but no chapter on urea. Urea is
often omitted in fluid used in in vitro experiments, or, if
present, the normal proportion between urea and other
solutes is not adequately taken into account. The normal
urea/Na concentration ratio in the urine is largely minored in
most in vivo studies in anesthetized animals because of the
intravenous infusion of isotonic saline currently administered
in such studies. However, including urea in the infusate
improves the stability of the results and certainly places the
kidney in a more physiologically relevant situation.200 If
nitrogenous wastes were excreted easily, this underrepresen-
tation of urea would not matter much, but several studies
have shown that increasing urine concentration (and thus
mainly urea concentration) may participate in glomerular
hyperfiltration,84 may accelerate deteroriation of renal
function,201–203 and increase albuminuria204–207 and blood
pressure.208 Moreover, it may be interesting to recall that, in
addition to its effect on the kidney, vasopressin has a direct
effect in the liver through V1a receptors,209–211 leading to
stimulation of glucose and urea synthesis212 and increased
blood glucose level in humans.213 Vasopressin is elevated in
diabetes mellitus,214 and several recent studies suggest that it
may participate in the incidence of this disease and in other
metabolic disturbances.215,216 Even if these results need to be
replicated and confirmed, they strengthen the concept that
water conservation—and thus urea concentration in the
urine—depending on vasopressin’s multiple actions, may have a
significant cost6 and can become deleterious in certain situations.
This review presents several novel hypotheses in an attempt
to provide new directions for research regarding urine
concentration and the role of urea in this complex process.
The first hypothesis about urea secretion in the medullary
pars recta is most likely correct because it is strongly
supported by many results accumulated over several decades
in humans and various experimental models. However, some
direct experimental demonstration of this secretion is missing,
except for the study of Kawamura and Kokko101 in rabbits.162
Microperfusion experiments of pars recta of normal rats and
mice, as well as micropuncture studies comparing urea
delivery in late proximal and early distal tubules in UT-A2 KO
mice, would provide definitive answers regarding this
proposed secretion.
Several polymorphisms of UT-A2 have been identified in
humans. Although the functional consequence of these
variants on urea transport have not been explored to our
knowledge, epidemiological studies in large populations
revealed that some of these variants are associated with
blood pressure and metabolic syndrome,217–219 suggesting
that UT-A2 and renal urea handling influence fluid balance in
humans. New studies should address the function of these
variants and attempt to better define the contribution of UT-
A2 to overall urea handling.
As already proposed by Schmidt-Nielsen34,136,139,220,221 in
several of her studies, it seems obvious now that urea excretion
in mammals is regulated. In addition to being filtered, urea
probably undergoes an active reabsorption when protein
intake is low, and an active secretion (probably secondary
active) on a normal or high protein intake. Moreover, an acute
regulation should also take place, reducing urea excretion
during a fast and increasing it after protein meals. Glucagon (a
hormone secreted after ingestion of proteins) and glucocorti-
coids may regulate the intensity of urea secretion in the pars
recta, either directly or indirectly. This needs to be confirmed
by specific experimental designs, either by acute application of
these hormones (or cAMP) in the bath of isolated perfused
pars recta, or by prior in vivo treatment. The prior influence of
a high protein intake or of an acute amino-acid load, shortly
before pars recta microdissection and perfusion, would also be
interesting to evaluate.
All other hypotheses, the actual magnitude of urea
secretion through SGLT1 in vivo, the possibility that glucose
could be secreted in the pars recta at least under certain
circumstances, the possibility that this glucose may serve to
feed lactate to the IM and be recycled in a Cori-like cycle, are
more speculative, although they are all based on several
converging indices and seem plausible. They need to be
evaluated by appropriate in vivo and in vitro experiments.
Finally, the possibility that urea escape through the bladder
wall might be prevented by the operation of an active urea
transporter located in the luminal membrane of umbrella
cells, opposite to the membrane expressing UT-B, could be
tested by measuring transepithelial unidirectional urea fluxes
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in the rat or mouse bladder in situ. This transporter might
share the same functional characteristics as that observed in
the very terminal portion of the IMCD.46
New theories may turn out to be incorrect. However, they
provide new food for thought and possibly additional new
ideas that are essential for science to progress. Old hypotheses
need to be revisited in the light of new results brought by
molecular biology that challenge our previous paradigms. It
is our hope that this review will stimulate further research in
the field of urea handling and will encourage more colleagues
to publish data about urea in renal studies.
NOTES ADDED IN PROOF
Note 1. A recent study now demonstrates that glucagon does
stimulate renal gluconeogenesis.
Mutel E, Gauther-Stein A, Abdul-Wahed A et al. Control
of blood glucose in the absence of heptaic glucose production
during prolonged fasting in mice. Induction of renal and
intestinal gluconeogenesis by glucagon. Diabetes 2011; 60:
3121–3131.
Note 2. A recent study described a new case of familial
autosomal dominant azotemia segregating with a duplication
of the UT-B gene. Affected individuals exhibit a marked
increase in UT-B protein abundance in a kidney biopsy and
in erythrocytes, and a three-fold acceleration of urea-induced
hemolysis. An enhanced permeability to urea in vasa recta
and erythrocytes cannot adequately explain the elevated
plasma urea and dramatic fall in FEurea (1.4%) seen in this
family. A more likely interpretation, in our view, is that an
overexpression of UT-B in the bladder urothelium is respon-
sible for an increased leakage of urea from bladder urine back
to the blood, that exceeds the capacity of the putative active
urea transporter to reclaim urea. This hypothesis needs to be
confirmed. According to data presented in a poster at the
American Society of Nephrology annual meeting, November
2011 (poster 2741), this new pedigree of familial azotemia
displays a more severe phenotype (higher plasma urea and
lower FEurea) than that described in previous studies
104–106 in
which we assume a loss of function of an active urea
transporter (see above). Alike many other genetic diseases,
familial azotemia may probably be due to different genetic
defects, with minor but discernable differences in phenotype.
Bokenkamp A, Sands JM, Wigman L et al. Familial azotemia
is caused by a duplication of urea transporter-B gene. J Am Soc
Nephrol 2011; 22 (online only): 750A.
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